Related Experiment Video
Updated: Jul 4, 2026

07:13
Fluorescent Lateral Flow Immunoassay Based on Quantum Dots Nanobeads
Published on: June 28, 2024
Silane-dextran chemistry on lateral flow polymer chips for immunoassays
Christina Jönsson1, Magnus Aronsson, Gerd Rundström
1Amic AB, Uppsala, Sweden.
Lab on a Chip
|June 28, 2008
Summary
Early disease diagnosis is improved with high-performance microfluidic chips. This study presents a novel surface chemistry for antibody immobilization on disposable chips, enhancing diagnostic capabilities for conditions like cardiovascular disease.
Area of Science:
- Biomedical Engineering
- Materials Science
- Analytical Chemistry
Background:
- Early disease diagnosis significantly improves patient prognosis for various conditions, including cardiovascular diseases.
- Disposable microfluidic chips offer a promising platform for high-performance diagnostic testing.
- Precise control over surface chemistry is essential for reliable liquid distribution in microfluidic devices.
Purpose of the Study:
- To develop and validate a novel surface hydrophilization and antibody immobilization protocol for cycloolefin-copolymer (COC) microfluidic test chips.
- To enable the use of disposable microfluidic chips for sensitive and reliable sandwich immunoassays.
- To demonstrate the stability and utility of the developed surface chemistry in a clinically relevant assay.
Main Methods:
- Fabrication of microfluidic chips via injection molding of Zeonor (COC).
- Development of a surface modification protocol involving direct silanisation of the COC substrate.
- Covalent coupling of dextran to amino groups for stable, hydrophilic surface coating and subsequent antibody immobilization.
Main Results:
- A stable, low-contact-angle surface coating was achieved using dextran, with stability lasting over two months.
- The developed surface chemistry enabled effective antibody immobilization for sandwich immunoassays.
- A C-reactive protein (CRP) assay demonstrated a low detection limit (2.6 ng/mL), a dynamic range of 10^2, and a coefficient of variance of 15%.
Conclusions:
- The novel surface hydrophilization and antibody immobilization protocol is effective for COC-based microfluidic diagnostic chips.
- The developed platform and surface chemistry support the creation of stable, reliable, and sensitive disposable diagnostic devices.
- This approach has the potential to advance early disease diagnosis through high-performance point-of-care testing.

